))
Medtronic's pulsed-field ablation wins FDA approval
Manage episode 389647673 series 3481361
Content provided by Fast Five by MassDevice. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fast Five by MassDevice or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 15, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. HeartBeam this week unveiled an artificial intelligence program for cardiac insights. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the goal of the AI program and HeartBeam's technology that will be used in the program. Microbot Medical and Corewell are collaborating on telerobotics for endovascular surgical robotics. Hear what the goal of the collaboration is and what each company brings to the partnership. The FDA has approved Glaukos' iDose TR glaucoma-treating drug delivery implant. Whooley explains what the approval covers and how the company plans to launch the implant. J&J's Biosense Webster treated its first patients in the company's dual-energy AFib ablation trial. The Fast Five hosts talk about the technology and some of the other AFib ablation companies in the playing field right now. Medtronic won a landmark FDA approval for its PulseSelect pulsed field ablation. Hear more about the approval, what PulseSelect is and when the company plans to start commercialization.
…
continue reading
161 episodes
Share
